Sara Feola

16PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyGene and molecular therapyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 12, 2025
Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapy.

Salvatore Russo, Yvonne Giannoula, Sara Feola

|Mar 08, 2024
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors.

Sara Feola, Firas Hamdan, Salvatore Russo

|Dec 01, 2023
Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR.

Francesco Manfredi, Lorena Stasi, Silvia Buonanno

|Nov 04, 2023
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors.

Jacopo Chiaro, Gabriella Antignani, Sara Feola

|Feb 25, 2023
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies.

Lorella Tripodi, Emanuele Sasso, Sara Feola

|Nov 17, 2022
Mannosylated Polycations Target CD206+ Antigen-Presenting Cells and Mediate T-Cell-Specific Activation in Cancer Vaccination.

Federica Bellato, Sara Feola, Gloria Dalla Verde

Pageof 3

Frequent Collaborators

13 joint publications

Vincenzo Cerullo

6 joint publications

Leena Ylösmäki

6 joint publications

Manlio Fusciello

5 joint publications

Firas Hamdan